PAR 3.57% 27.0¢ paradigm biopharmaceuticals limited..

Paradigm patent rejection

  1. 842 Posts.
    lightbulb Created with Sketch. 255
  2. 4,110 Posts.
    lightbulb Created with Sketch. 6576
    Hmm might need more time but at a glance....and remember, I am not a patent lawyer! Beyond my skill set here..so very happy to get others opinions!



    1) Seems to bring up the fact that they want to see ranges of % in terms of postulated benefits:

    Ie don't just say Greater than 35% and leave it like that, say 35 - 60% range of benefit could possibly be expected etc. Don't leave it open ended (inferring could be to 100%).


    2) Yes prior art, but don't we own the Ghosh Patent effectively?

    Felson is also on our books, may need some collaboration if we are to pursue this? Ie we effectively take over his claim/prior art as it were, with his permission?


    3) Some paragraph on "The skilled artesian would expect an improvement of symptoms"
    Case of obviousness. Not sure about this one and whether we can argue this.




    Certainly think it is one for our patent lawyer to go over....I know it is important to get this sewn up...I know we are effectively covered with manufacturing and supply side but always better to have IP in place. Also NGF (patent) overlap is there?



    My views.





 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
27.0¢
Change
-0.010(3.57%)
Mkt cap ! $94.44M
Open High Low Value Volume
28.0¢ 29.0¢ 27.0¢ $127.7K 460.1K

Buyers (Bids)

No. Vol. Price($)
12 287444 27.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 100870 1
View Market Depth
Last trade - 16.10pm 17/05/2024 (20 minute delay) ?
Last
27.0¢
  Change
-0.010 ( 5.69 %)
Open High Low Volume
28.5¢ 29.0¢ 27.0¢ 132157
Last updated 15.59pm 17/05/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.